CareDx

CAREDX INC

CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.

Acciones que se mueven

ARHS

BASE

CAPR

CDNA

CTOR

DGLY

HLMN

ICCT

NTHI

TILE

Xos sorprende al mercado con sólidos resultados en 2024 y hace subir sus acciones antes de la apertura. Descubre más movimientos aquí.

Acciones de Xos (XOS) suben alrededor de un 9%; Aquí están 20 acciones que se mueven en el premercado de EE. UU.

News

Pre-Market Outlook

Markets

Movers

Trading Ideas

AAMI

ACEL

AXON

CLIK

ENVB

FLYW

HCTI

LBTYK

LMND

NAMS

PITA

PRCH

SMCI

ZoomInfo sorprende con resultados mejores de lo esperado y sus acciones suben un 19,6%. Descubre qué otras acciones se están moviendo hoy.

Acciones de ZoomInfo se disparan un 20%; 20 acciones que se están moviendo en el premercado de EE.UU.

Equities

Tech

ETFs

ADPT

ARKG

ARKK

PLTR

VCYT

Ark Invest sorprende con grandes movimientos en Palantir y Tempus AI. Descubre el impacto de estas decisiones clave.

Cathie Wood apuesta 12,2M$ en Tempus AI (TEM) mientras reduce exposición a Palantir (PLTR)

CareDx Inc

CANADIAN TIRE LTD A by Canadian Tire Corp. Ltd.

Canadian Tire Corp Ltd

Press Releases

CareDx Announces Proposed Draft LCD That Affirms Surveillance Testing Coverage for Solid Organ Transplant Rejection

CareDx to Report Second Quarter 2025 Financial Results

CareDx Announces Landmark Data in AI-Powered Transplant Diagnostics Showcased in Over 40 Abstracts and 16 Oral Presentations at the 2025 World Transplant Congress

CareDx Announces Landmark KOAR Study Published in the American Journal of Transplantation

CareDx Announces Second Quarter 2025 Financial Results

CareDx Announces Appointment of Nathan Smith as Chief Financial Officer

CareDx to Participate in Wells Fargo Healthcare Conference

CareDx Issues Comment Letter on Draft LCD Policy

CareDx Announces New IVD Products and IVDR Certification for AlloSeq® Tx and QTYPE® at the 2025 American Society of Histocompatibility & Immunogenetics Annual Meeting

CareDx to Report Third Quarter 2025 Financial Results on November 4, 2025

Absci

Arbutus Biopharma Corporation - Common Stock

Arbutus Biopharma

Akebia Therapeutics

Astria Therapeutics

ArriVent BioPharma

Anavex Life Sciences Corp. - Common Stock

Anavex Life Sciences

BridgeBio Oncology Therapeutics, Inc. - Common Stock

BridgeBio Oncology

Bicara Therapeutics

Day One Biopharmaceuticals, Inc. - Common Stock

Day One Biopharmaceutical

Geron

Gyre Therapeutics

Iovance Biotherapeutics, Inc. - Common Stock

Iovance Biotherapeutics

Inventiva S.A. - American Depository Shares

Inventiva

Kura Oncology

MeiraGTx Hldgs

Myriad Genetics

Nurix Therapeutics

Pharming Group N.V. - ADS, each representing 10 ordinary shares

Pharming

Palvella Therapeutics, Inc. - Common Stock

Palvella Therapeutics

Rezolute

Savara

Tyra Biosciences

UroGen Pharma

Valneva

Vir Biotechnology

BTIG

Wells Fargo

Craig-Hallum

Stephens & Co.

HC Wainwright & Co.

Comments

CareDx

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL